Login

Create Account

AAOS 2025 Registration Is Now Open! Sign Up Early and Save.

AAOS.org is currently experiencing longer than usual load times when logging in. We are working to correct this issue and hope to resolve it shortly. We apologize for the inconvenience and thank you for your patience.

AAOS Now, April 2018

AAOS Tackles Controversies Surrounding the Use of Biologics in Orthopaedic Surgery

Clinical use of biologics to treat orthopaedic problems has greatly outpaced the evidence. This rise is primarily due to widespread use of “minimally manipulated” autologous therapies that are either blood products or have been interpreted as falling within the Public Health Service Act Section 361 pathway, which does not require premarket approval from the U.S. Food and Drug Administration (FDA).

AAOS Now, April 2018

AAOS Tackles Controversies Surrounding the Use of Biologics in Orthopaedic Surgery